Creative Medical Technology Holdings, Inc. (CELZ)
Oxford Ledge is still expanding full research coverage of CELZ. A live quote, fundamentals, and analysis are available in the app; the SEC-sourced material below is what we currently have indexed here.
Business summary
A biotechnology company developing cell-based regenerative therapies through multiple clinical platforms and subsidiaries.
SEC filings
- 8-K Entry into material agreement; 3.02; Departure/election of directors or officers; Financial statements and exhibits 2026-07-02
- S-1/A Amended registration statement 2026-06-26
- S-1 IPO / securities registration statement 2026-06-25
- 10-Q Quarterly financial report (unaudited) 2026-05-08
- 10-K/A Amended annual report 2026-04-24
Source: SEC EDGAR.
Insider activity
5 recent insider (SEC Form 4) filings on record for CELZ. View the transactions in the terminal.
Source: SEC EDGAR (Form 4).
- Open CELZ in the Oxford Ledge terminal — live quote, chart, and analysis in the app.
- Browse the covered-stock index
- Learn to analyze stocks yourself
The material above is drawn from public SEC EDGAR filings and is provided for educational purposes, not as investment advice. Live pricing and fundamentals are available in the terminal.